Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Vimpat® (lacosamide) – Expanded indication
November 6, 2017 – UCB announced the FDA approval of Vimpat (lacosamide) tablets and oral solution, for the treatment of partial-onset seizures in patients 4 years of age and older.
